Evidence map›Paper›PMID 34744164›Full record

ArticleMolecular psychiatry2022

Correction: GRK3 deficiency elicits brain immune activation and psychosis.

Carl M Sellgren, Sophie Imbeault, Markus K Larsson, Alfredo Oliveros, Ida A K Nilsson, Simone Codeluppi, Funda Orhan, Maria Bhat, Maximilian Tufvesson-Alm, Jessica Gracias and 19 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Carl M Sellgren *Department of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Sophie Imbeault *Department of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Markus K LarssonDepartment of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Alfredo OliverosDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, USA.
Ida A K NilssonTranslational Psychiatry, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-7676-4299
Simone CodeluppiDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Funda OrhanDepartment of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Maria BhatResearch and Development, Innovative Medicines, Personalised Healthcare and Biomarkers, Translational Science Centre, Science for Life Laboratory, AstraZeneca, Solna, Sweden.
Maximilian Tufvesson-AlmDepartment of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Jessica GraciasDepartment of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-1730-7821
Magdalena E KegelDepartment of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Yiran ZhengDepartment of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Anthi FakaDepartment of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Marie SvedbergDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Susan B PowellDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Sorana CaldwellDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Mary E KamenskiDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Marquis P VawterFunctional Genomics Laboratory, Department of Psychiatry and Human Behavior, University of California Irvine School of Medicine, Irvine, CA, USA.
Anton SchulmannFunctional Genomics Laboratory, Department of Psychiatry and Human Behavior, University of California Irvine School of Medicine, Irvine, CA, USA.ORCID http://orcid.org/0000-0002-6323-4969
Michel GoinyDepartment of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Camilla I SvenssonDepartment of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Tomas HökfeltDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Martin SchallingTranslational Psychiatry, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Lilly SchwielerDepartment of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Simon CervenkaCentre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm & Stockholm Health Care Services, Region Stockholm, Sweden.
Doo-Sup ChoiDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-6796-9938
Mikael LandénInstitute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden.
Göran EngbergDepartment of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden. goran.engberg@ki.se.ORCID http://orcid.org/0000-0003-1659-5232
Sophie ErhardtDepartment of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34744164
PMCPMC9119248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.